Evidence map›Paper›PMID 22090486›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

State-dependent, bidirectional modulation of neural network activity by endocannabinoids.

Richard Piet, André Garenne, Fanny Farrugia, Gwendal Le Masson, Giovanni Marsicano, Pascale Chavis, Olivier J Manzoni

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. CBScientific reports · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bimodal control of fear-coping strategies by CB₁ cannabinoid receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Richard PietNeurocentre Magendie INSERM U862, 33077 Bordeaux Cedex, France. richard.piet@otago.ac.nz
André Garenne
Fanny Farrugia
Gwendal Le Masson
Giovanni Marsicano
Pascale Chavis
Olivier J Manzoni
Université de Bordeaux · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endocannabinoid (eCB) system and the cannabinoid CB1 receptor (CB1R) play key roles in the modulation of brain functions. Although actions of eCBs and CB1Rs are well described at the synaptic level, little is known of their modulation of neural activity at the network level. Using microelectrode arrays, we have examined the role of CB1R activation in the modulation of the electrical activity of rat and mice cortical neural networks in vitro. We find that exogenous activation of CB1Rs expressed on glutamatergic neurons decreases the spontaneous activity of cortical neural networks. Moreover, we observe that the net effect of the CB1R antagonist AM251 inversely correlates with the initial level of activity in the network: blocking CB1Rs increases network activity when basal network activity is low, whereas it depresses spontaneous activity when its initial level is high. Our results reveal a complex role of CB1Rs in shaping spontaneous network activity, and suggest that the outcome of endogenous neuromodulation on network function might be state dependent.

Indexed as

Endocannabinoids4-AminopyridineAction PotentialsAnimalsAnimals, NewbornBenzothiadiazinesBrainCannabinoid Receptor ModulatorsCells, CulturedElectric StimulationExcitatory Amino Acid AntagonistsGABA AntagonistsIn Vitro TechniquesMiceMice, TransgenicNerve Net2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline2-amino-5-phosphopentanoic acid4-AminopyridineAM 251BenzothiadiazinesCannabinoid Receptor ModulatorsCGP 54626cyclothiazideEndocannabinoidsExcitatory Amino Acid AntagonistsGABA AntagonistsOrganophosphorus CompoundsPicrotoxinPiperidinesPotassium Channel BlockersPyrazolesQuinoxalinesReceptor, Cannabinoid, CB1Sodium Channel BlockersTetrodotoxinValine

Identifiers

PMID22090486
PMCPMC6633318
OpenAlexW2025148615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.